| ST0109-1 |
Anti-Human CD20 (Obinutuzumab) - Dylight 488 - 100 µg | CD20 | 100 μg | $341.25 | |
| ST0045-1 |
Anti-Human CD20 (Rituximab) - Dylight® 488 - 100 µg | CD20 | 100 μg | $341.25 | |
| ST0067-1 |
Anti-Human CD257 (BAFF) (Tabalumab) - Dylight® 488 - 100 µg | BAFF | 100 μg | $341.25 | |
| ST0051-1 |
Anti-Human CD279 (PD-1) (Nivolumab) - Dylight® 488 - 100 µg | PD-1 | 100 μg | $341.25 | |
| ST0048-1 |
Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Dylight® 488 - 100 µg | CD49d | 100 μg | $341.25 | |
| ST0019-1 |
Anti-Human CD52 (Alemtuzumab) - Dylight® 488 - 100 µg | CD52 | 100 μg | $341.25 | |
| ST0042-1 |
Anti-Human EGFR (Cetuximab) - Dylight® 488 - 100 µg | EGFR | 100 μg | $341.25 | |
| ST0026-1 |
Anti-Human HER-2 (Trastuzumab) - Dylight® 488 - 100 µg | HER-2/neu | 100 μg | $341.25 | |
| ST0037-1 |
Anti-Human IL 12/23 (Briakinumab) Dylight® 488 - 100 µg | IL-12/IL-23 p40 | 100 μg | $341.25 | |
| ST0014-1 |
Anti-Human IL-2R alpha (CD25) (Basiliximab) - Dylight® 488 - 100 µg | CD25 | 100 μg | $341.25 | |
| ST0059-1 |
Anti-Human IL-6 (Sarilumab) Dylight® 488 - 100 µg | IL-6 | 100 μg | $341.25 | |
| ST0054-1 |
Anti-Human OX40L (Oxelumab) - Dylight® 488 - 100 µg | TNFSF4 | 100 μg | $341.25 | |
| ST0073-1 |
Anti-Human PD-L1 (Atezolizumab) - Dylight®488 - 50 µg | PD-L1 | 50 µg | $341.25 | |
| ST0009-1 |
Anti-Human TNF alpha (Adalimumab) - Dylight 488® - 100 µg | TNF-alpha | 100 μg | $341.25 | |
